Detalhe da pesquisa
1.
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases.
Vaccines (Basel)
; 12(4)2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675815